NEW YORK (Reuters Health) - Most older men with prostate cancer found by prostate-specific antigen (PSA) tests and biopsies opted for treatment in a new study - even if signs pointed to their disease ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
DEAR DR. ROACH: I am a 53-year-old healthy male, and I always request to check my PSA levels each year. My 57-year-old brother’s new doctor denied his request for a routine PSA check on their initial ...
IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade ...
Should men routinely get a blood test that can detect prostate cancer before symptoms develop? A federal panel this week said the commonly used procedure, called a PSA test, causes more harm than good ...
For decades, the story of prostate cancer screening has been dominated by three letters: P-S-A. The Prostate-Specific Antigen blood test is the first line of defense for millions of men. Yet, for all ...
The Prostate Health Index (phi) (Beckman Coulter) significantly changes urologists' opinions about whether men with certain results on prostate-specific antigen (PSA) screening should or should not ...
A urine test could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 ...
Researchers have created a urine test for prostate cancer that could make unnecessary biopsies a thing of the past. The high-performing diagnostic accurately detects prostate cancer, with very few ...
The PSA test is an imperfect way to screen men for prostate cancer. But until recently, it was seen as the best option available. The test measures the amount of prostate specific antigen, or PSA, in ...
The recommendation Monday by the prestigious United States Preventive Services Task Force (USPSTF) that the widely used PSA test for prostate cancer no longer be used routinely for men of any age is ...